Dr Kath Mackay is Chief Scientific Officer for Bruntwood SciTech and Managing Director of its Alderley Park campus, the UK’s largest single site life science innovation campus. Her responsibilities include stimulating new business ventures and managing further development of the campus. Kath joined Bruntwood SciTech in 2019 from Innovate UK, the UK’s innovation agency, which is part of UK Research & Innovation, the £7bn body tasked with creating the best possible environment for research and innovation to flourish. In her most recent role there, Kath was Director for Ageing Society, Health and Nutrition, and part of the executive management team. She led a team of PhD educated Innovation Leads and was responsible for growing and scaling businesses working in the biomedical, health, agriculture and food sectors, including development of new challenges under the Government’s Industrial Strategy. Previously she was on the senior management team leading initiatives in biomedical innovation and was Innovation Lead for Advanced Therapies, which spearheaded the delivery of investment into the UK’s growing cell and gene therapy industry. Kath’s earlier career included Business Development Director with Epistem, then an AIM listed, VC backed personalised medicine company Kath has a PhD in Pharmacology from the University of Manchester. She is an experienced public speaker and internal and external industry events. Additionally, she has a keen interest and been actively involved in mentoring and developing employees. She has been a mentor with MassChallenge UK, (part of a global not-for-profit start up accelerator for entrepreneurs) and the Healthcare Businesswomen’s Association.